EP Life Sciences Ltd. is a hedge fund based in New York, New York. According to its most recent Form D, filed Mar 16, 2026, the fund has sold $52,817,488 of interests to 22 investors since its first sale in Jul 2021. The minimum investment it accepts from an outside investor is $100,000. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Kabir Kapoor; Marty Piccinich; Michael Fierro.
Performance
No verified returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to AltMountain directly.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $52,817,488Cumulative sales reported on Form D
- Investors
- 22
- First sale
- Jul 1, 2021
- Minimum investment
- $100,000
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Kabir Kapoor; Marty Piccinich; Michael Fierro
- Latest Form D
- Mar 16, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about EP Life Sciences Ltd.
What is the minimum investment for EP Life Sciences Ltd.?
According to its latest Form D, filed Mar 16, 2026, the minimum investment EP Life Sciences Ltd. accepts from an outside investor is $100,000.
Who can invest in EP Life Sciences Ltd.?
EP Life Sciences Ltd. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has EP Life Sciences Ltd. raised?
EP Life Sciences Ltd. reports $52,817,488 sold from 22 investors on its Form D filed Mar 16, 2026. This is cumulative sales since the offering began, not current assets or performance.
Where is EP Life Sciences Ltd. based?
EP Life Sciences Ltd. is based in New York, New York.
When did EP Life Sciences Ltd. launch?
EP Life Sciences Ltd. reports its first sale in Jul 2021.
Size compared with every hedge fund
Raised more than 44% of the 2,544 hedge funds based in New York, and more than 47% of all 10,308 that report sales.